Katharina M. Rund

Development of an Optimized LC-MS Method for the Detection of Specialized Pro-Resolving Mediators in Biological Samples

Laura Kutzner, Katharina M. Rund, Annika I. Ostermann et al. · Frontiers in Pharmacology · 2019 · 112 citations · Full text

Life Sciences, Biochemistry, Inflammation +14

Development of an LC-ESI(-)-MS/MS method for the simultaneous quantification of 35 isoprostanes and isofurans derived from the major n3- and n6-PUFAs

Katharina M. Rund, Annika I. Ostermann, Laura Kutzner et al. · Analytica Chimica Acta · 2017 · 98 citations · Full text

Natural Sciences, Biochemistry, Chemistry +10

Stability of oxylipins during plasma generation and long-term storage

Elisabeth Koch, Malwina Mainka, Annika I. Ostermann et al. · Talanta · 2020 · 66 citations

Pharmacy, Biochemistry, Pharmaceutical Analysis +13

Targeting esterified oxylipins by LC–MS - Effect of sample preparation on oxylipin pattern

Annika I. Ostermann, Elisabeth Koch, Katharina M. Rund et al. · Prostaglandins & Other Lipid Mediators · 2019 · 60 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +10

Influence of weight reduction on blood levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and oxylipins in obese subjects

Katharina Möller, Annika I. Ostermann, Katharina M. Rund et al. · Prostaglandins Leukotrienes and Essential Fatty Acids · 2015 · 50 citations

Agriculture, Nutrition, Nutritional Sciences +13